Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 11 Mar 2026 for AbbVie Inc., €414k. Read the official filing
Filing timeline
BuySaleDavid Ryan Purdue
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
David Ryan Purdue: trading record in brief
David Ryan Purdue appears in our data through filings on AbbVie Inc. shares, published by SEC (Form 4). In total, 4 filings cover trades dated from 18 February 2026 to 4 March 2026.
On the market, this insider has only sold: 1 sale, €1.1M in total. Outside the open market, there are 3 share grants.
The record was last updated on 11 March 2026 with a share grant (€414k) in AbbVie Inc. Typically, a trade is published a median of 3 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to David Ryan Purdue
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
2,108 shares@ US$232.08Common Stock, $0.01 par valueSEC:0002057696-26-000010:0
5,230 shares@ US$233.56Common Stock, $0.01 par valueSEC:0002057696-26-000008:0
2,692 shares@ US$232.08Common Stock, $0.01 par valueSEC:0002057696-26-000004:0
2,505 shares0Common Stock, $0.01 par valueSEC:0002057696-26-000002:0
4 of 4 declarations
